Publications by authors named "Paul Berg"

Claim this Profile
M
Model-Informed Drug Development for Daprodustat Supports the Design of Individualized Dosing Regimens in Chronic Kidney Disease Patients With Anemia.
Kelly M Mahar, Shuying Yang, Brendan Johnson, Sandra A G Visser, Paul van den Berg

Clin Pharmacol Ther· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A century of anthropogenic perturbations impact genomic signatures of the iconic migratory Atlantic cod.
Cecilia Helmerson, Joël M Durant, Siv Nam Khang Hoff, Marine Servane Ono Brieuc, Paul Ragnar Berg

Sci Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential sources of impacts linked to ciliate epibiont occurrence on the macrobenthic invertebrates in the Coringa Mangrove Ecosystem: Preliminary documentation.
Appalanaidu Sura, Uma Sankar Panda, Sivasankar Ramakrishnan, Kumaraswami Munnoor, Akhilesh Vijay, Paul Ragnar Berg

Environ Sci Pollut Res Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Potential sources of impacts linked to ciliate epibiont occurrence on the macrobenthic invertebrates in the Coringa Mangrove Ecosystem: Preliminary documentation.
Appalanaidu Sura, Uma Sankar Panda, Sivasankar Ramakrishnan, Kumaraswami Munnoor, Akhilesh Vijay, Paul Ragnar Berg

Environ Sci Pollut Res Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated Longitudinal Population Dose-Hemoglobin Response of Daprodustat Following Dose Titration in Patients With Anemia in Chronic Kidney Disease.
Kelly M Mahar, Martijn van Noort, Paul van den Berg, Shuying Yang, Sandra A G Visser

Clin Pharmacol Ther· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incident Use of Hydroxychloroquine for the Treatment of Rheumatoid Arthritis and Systemic Lupus Erythematosus During the COVID-19 Pandemic.
Núria Mercadé-Besora, Yuchen Guo, Mike Du, Xintong Li, Juan Manuel Ramírez-Anguita, Paul Berg

Arthritis Care Res (Hoboken)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacodynamics of finerenone in patients with chronic kidney disease and type 2 diabetes: Insights based on FIGARO-DKD and FIDELIO-DKD.
Thomas Eissing, Sebastiaan Camiel Goulooze, Paul van den Berg, Martijn van Noort, Martijn Ruppert

Diabetes Obes Metab· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation: A Randomized Clinical Trial.
Stephen J Nicholls, Steven E Nissen, Cynthia Fleming, Shweta Urva, Jeffrey Suico, Paul H Berg

JAMA· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How genomics can help biodiversity conservation.
Kathrin Theissinger, Carlos Fernandes, Giulio Formenti, Iliana Bista, Paul R Berg

Trends Genet· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hidden but revealed: After years of genetic studies behavioural monitoring combined with genomics uncover new insight into the population dynamics of Atlantic cod in Icelandic waters.
Christophe Pampoulie, Paul Ragnar Berg, Sissel Jentoft

Evol Appl· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: Erratum.
Rosie S Jones, Patricia S Smith, Paul H Berg, Amparo de la Peña, Paul P Cook

Clin Med Insights Circ Respir Pulm Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polygenic plague resistance in the great gerbil uncovered by population sequencing.
Pernille Nilsson, Mark Ravinet, Yujun Cui, Paul R Berg, Yujiang Zhang

PNAS Nexus· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) intercalated TKI with chemotherapy for -mutated nonsmall cell lung cancer.
Rolof G P Gijtenbeek, Vincent van der Noort, Joachim G J V Aerts, Jeske A Staal-van den Brekel, Egbert F Smit, Paul M van den Berg

ERJ Open Res· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of LY3127804, an Anti-Angiopoietin-2 Antibody, in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial in Patients Hospitalized with Pneumonia and Presumed or Confirmed COVID-19.
Rosie S Jones, Patricia S Smith, Paul H Berg, Amparo de la Peña, Paul P Cook

Clin Med Insights Circ Respir Pulm Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Finerenone Dose-Exposure-Response for the Primary Kidney Outcome in FIDELIO-DKD Phase III: Population Pharmacokinetic and Time-to-Event Analysis.
Paul van den Berg, Martijn Ruppert, Emir Mesic, Nelleke Snelder, Andreas Seelmann

Clin Pharmacokinet· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding effect site pharmacology of uprifosbuvir, a hepatitis C virus nucleoside inhibitor: Case study of a multidisciplinary modeling approach in drug development.
Paul van den Berg, Wei Gao, Maurice J Ahsman, Leticia Arrington, Filippos Kesisoglou

CPT Pharmacometrics Syst Pharmacol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A new microdialysis probe for continuous lactate measurement during fetal monitoring: Proof of concept in an animal model.
Froukje Tigchelaar, Henk Groen, Magnus Westgren, Kirsten D Huinink, Thomas Cremers, Paul P van den Berg

Acta Obstet Gynecol Scand· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of lasmiditan on simulated driving performance: Results of two randomized, blinded, crossover studies with placebo and active controls.
Eric M Pearlman, Darren Wilbraham, Ellen B Dennehy, Paul H Berg, Max Tsai

Hum Psychopharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Colorectal Cancer Screening in a Rural Setting: A Randomized Study.
Kelly A Hirko, Sue A Lennon, Todd Lucas, David C Miller, Masahito Jimbo, Paul D Berg

Am J Prev Med· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Army Paradox: Leader and Follower Education.
Ted Thomas, Paul Berg

New Dir Stud Leadersh· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and late onset pre-eclampsia and small for gestational age risk in subsequent pregnancies.
Thomas P Bernardes, Ben W Mol, Anita C J Ravelli, Paul van den Berg, H Marike Boezen

PLoS One· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abuse Potential of Lasmiditan: A Phase 1 Randomized, Placebo- and Alprazolam-Controlled Crossover Study.
Darren Wilbraham, Paul H Berg, Max Tsai, Emily Liffick, Li Shen Loo

J Clin Pharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of UGP2 in brain leads to a severe epileptic encephalopathy, emphasizing that bi-allelic isoform-specific start-loss mutations of essential genes can cause genetic diseases.
Elena Perenthaler, Anita Nikoncuk, Soheil Yousefi, Woutje M Berdowski, Maysoon Alsagob, Paul van den Berg

Acta Neuropathol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Issues Impacting Adverse Event Frequency and Severity: Differences Between Randomized Phase 2 and Phase 3 Clinical Trials for Lasmiditan.
David Kudrow, John H Krege, Hans P Hundemer, Paul H Berg, Rashna Khanna

Headache· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials.
Robert E Shapiro, Helen M Hochstetler, Ellen B Dennehy, Rashna Khanna, Erin Gautier Doty, Paul H Berg

J Headache Pain· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis